Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
National Institutes of Health
Free. Verify your email, then we send one reminder only.
- Posted
- Oct 23, 2025
- Amount
- $50,000 - $600,000
- Closes
- Oct 19, 2026 (in 82 days)
Classification and identifiers
- Solicitation number
- RFA-CA-27-020
- Assistance listing (CFDA)
- 93.395
Amount
$50,000 - $600,000
Who can apply
Small businesses and State government agencies can all apply here. Check the eligibility details below to see if your organization fits.
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
About this opportunity
This Notice of Funding Opportunity (NOFO) invites applications for advanced development and enhancement of emerging informatics technologies to improve the acquisition, analysis, visualization, and interpretation of data across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology. As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Program, this NOFO is focused on advancing emerging informatics technology, defined as one that has passed the initial prototyping and pilot development stage, has demonstrated potential to have a significant and broader impact, has compelling reasons for further improvement and enhancement, and has not been widely ...
Related opportunities
- Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)National Institutes of HealthCloses in 82 daysUp to $600K
- Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)National Institutes of HealthCloses Oct 2027Up to $300K
- Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)National Institutes of HealthCloses Jul 2029